It is critical for health care and life sciences businesses to understand what might and might not change during this transitionary period. How can you advocate for your needs and priorities in a time of such uncertainty?
On this episode, Epstein Becker Green (EBG) attorneys James Boiani, Rachel Snyder Good, Marjorie Scher, and Rob Wanerman discuss the proposed leadership of the U.S. Department of Health and Human Services under the second Trump administration and the top-ticket items for these potential new leaders.
Chevron deference article mentioned in today’s show
This podcast was recorded on January 23, 2025. Since then, EBG has put out several important free resources in response to President Trump's executive orders and other executive actions to make sure EBG subscribers have the information they need to navigate any uncertainty. Some examples include:
DEI and Affirmative Action Programs Blitzed, While Executive Order 11246 Is Revoked
Navigating Executive Orders: Insights and What Lies Ahead
If you are interested in getting access to EBG’s publicly available shared information, please use the following link to subscribe: https://www.ebglaw.com/subscribe.
About the Diagnosing Health Care Podcast
The Diagnosing Health Care® podcast series examines the business opportunities and solutions that exist despite the high-stakes legal, policy, and regulatory issues that the health care industry faces.
Email Notifications
Follow Us
Never miss an episode! Subscribe to Diagnosing Health Care on your preferred platform:
Also on Audible | Deezer | Goodpods | iHeartRadio | PlayerFM | Pocket Casts | YouTube Music
People
- Member of the Firm
- Strategic Counsel
- Senior Counsel
- Member of the Firm
Services
- Drug and Medical Device Coding, Coverage, and Payment
- Drug Pricing Policy & Reporting
- FDA Inspections and Enforcement
- Government and Commercial Coding, Coverage, and Payment
- Health Care
- Health Care and Life Sciences Investigations and Enforcement
- Health Insurance Exchanges
- Health Policy and Legislation
- Life Sciences
- Managed Care
- Medicare Advantage
- Regulatory Strategy, Product Development, and Product Approvals